We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Novel Biopsy Robot Could Improve Disease Diagnosis

By HospiMedica International staff writers
Posted on 31 Jan 2016
An innovative biopsy robot under development combines features of both magnetic resonance imaging (MRI) and ultrasound (US), aiming to improve the identification of breast cancer and muscle diseases. More...


Researchers at the University of Twente (Enschede, The Netherlands), Siemens (Munich, Germany), KUKA (Augsburg, Germany), and other companies and institutions participating in the MRI and Ultrasound Robotic Assisted Biopsy (MURAB) project joined to build a robot that combines the best aspects of an MRI scan with cheaper technologies, such as an US sensor and a pressure sensor, with the potential to drastically improve the clinical workflow by precise targeting of small lesions visible under MRI, but not under US.

The system will be based on a robotically steered US transducer with acoustically transparent force sensing, which will be autonomously moved to optimally acquire volumetric and elastographic data. Thanks to an innovative technique, the system will first optimally register the acquired volume to the MRI scan. Once completed, the radiologist can then select the target lesion on the MRI; the robot will then steer the instrument to the exact desired location by adapting the insertion angle on the basis of real time US measurements; tissue deformations will be predicted based on the acquired elastographic measurements.

“Patients need to spend just 15 to 20 minutes in the MRI scanner; this produces an offline MRI image that you can combine, during the biopsy, with online images from the ultrasound sensor,” said UT researcher and PhD candidate Foad Sojoodi Farimani, MSc. “One of the biggest challenges in this project is to use the precise MRI image to locate suspicious tissue in the much more indistinct ultrasound image.”

The technologies developed within MURAB will also have the potential to improve other clinical procedures, such as breast cancer diagnostics and muscle disease diagnostics.

Related Links:

University of Twente
Siemens
KUKA



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Infrared Digital Thermometer
R1B1
Blood Bank Refrigerator
MBR-705GR-PE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.